We spoke to Professor David Playford (University of Notre Dame, Perth, Australia) regarding diastolic function and dysfunction, the National Echo Database Australia (NEDA), and then focused on his recent study on diastolic function and mortality.
Questions
- What are the prognostic implications of diastolic dysfunction? (0:07)
- How do you classify patients by diastolic function? (1:18)
- Could you tell us a little about the National Echo Database Australia (NEDA)? (3:20)
Speaker disclosures: Professor David Playford has no conflict of interest to declare in relation to this video. NEDA was originally established with funding support from Actelion Pharmaceuticals, Bayer Pharmaceuticals, GlaxoSmithKline. Both NEDA (#1055214) and SS (#11358940) are supported by the National Health and Medical Research Council of Australia.
Support: Commissioned, edited and funded by Touch Medical Media.
Published: 21st September 2020
